FDA Issues Warning To CBD Companies

On November 1st, the U.S. Food and Drug Administration (FDA) published a press release addressing warning letters issued to four companies. The warning letters, sent to companies marketing cannabidiol (CBD) products with therapeutic claims, cites unsubstantiated claims about their products’ ability to treat or cure cancer and other diseases. A […]

Shimadzu, Cure And CK Sciences Partner On R&D of Pharmaceutical Cannabis Products

Yesterday, Shimadzu announced the formation of a partnership with Cure Pharmaceutical Group and CK Sciences to research and develop pharmaceutical cannabis-based products, according to a press release. The three organizations entered a collaborative agreement with the goal of researching and developing products, then moving them through clinical trials using FDA […]

EVIO Labs Expands To Florida

Currently, there are no lab testing regulations for Florida’s medical cannabis market. Chris Martinez, co-founder and chief operating officer of EVIO Labs Florida, a veteran-owned business, is looking to change that. Chris Martinez, co-founder and chief operating officer of EVIO Labs Florida When Martinez co-founded EVIO Labs Florida, he saw […]

What’s Happening on Capitol Hill? Part 3: The Medical Bills

This article continues the bill-by-bill review begun in the August 1st article of cannabis reform legislation proposed in the 115th Congress. In the next article and final piece in this series, we will examine the banking and tax reform bills related to cannabis. Medical Cannabis Reform Bills  1008 – Therapeutic […]

Implementing a HACCP Plan in Cannabis Processing

Hazard analysis and critical control points (HACCP) is a robust management system that identifies and addresses any risk to safety throughout production. Originally designed for food safety through the entire supply chain, the risk assessment scheme can ensure extra steps are taken to prevent contamination. The FDA as well as […]

Quality Controls and Medical Cannabis: What We Can Learn from Pharma

When we discuss growing and producing medical cannabis, we must think of it as a medicine. By definition, it is a substance intended to assist you with a medical condition, to help you feel better and not harm you. Drugs produced in the pharmaceutical industry go through extensive quality controls […]

Side Effects Emerge After Approval for Many U.S. Drugs – High Times

BY LINDSEY TANNERAP MEDICAL WRITER CHICAGO (AP) — Almost one-third of new drugs approved by U.S. regulators over a decade ended up years later with warnings about unexpected, sometimes life-threatening side effects or complications, a new analysis found. The results covered all 222 prescription drugs approved by the U.S. Food […]

Under Donald Trump, It’s Boom Times for Drug Fraudsters – High Times

In 2009, Alfred Caronia, then a sales representative for a pharmaceutical company working in New York City and on Long Island, was convicted of federal charges for telling doctors tall tales about the drug he was selling. Caronia worked for a company called Orphan Medical, the manufacturer and marketer of […]